Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor

Nuska Tschammer, Stefan Bollinger, Terry Kenakin and Peter Gmeiner
Molecular Pharmacology March 2011, 79 (3) 575-585; DOI: https://doi.org/10.1124/mol.110.068106
Nuska Tschammer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Bollinger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terry Kenakin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Gmeiner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 79 no. 3 575-585
DOI 
https://doi.org/10.1124/mol.110.068106
PubMed 
21163968

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 9, 2010
  • Accepted December 16, 2010
  • Published online February 18, 2011.

Article Versions

  • Earlier version (December 16, 2010 - 11:11).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Nuska Tschammer,
  2. Stefan Bollinger,
  3. Terry Kenakin and
  4. Peter Gmeiner
  1. Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich Alexander University, Erlangen, Germany (N.T., S.B., P.G.); and Department of Biological Reagents and Assay Development, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina (T.K.)
  1. Address correspondence to:
    Prof. Peter Gmeiner, Department of Chemistry and Pharmacy, Friedrich Alexander University, Schuhstraße 19, D-91052 Erlangen, Germany. E-mail: peter.gmeiner{at}medchem.uni-erlangen.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2010 to August 2022

AbstractFullPdf
Dec 2010124082
Jan 2011840104
Feb 2011174879
Mar 20111993446
Apr 2011692621
May 2011902331
Jun 2011532225
Jul 2011461021
Aug 2011311321
Sep 2011442411
Oct 2011201312
Nov 2011512431
Dec 2011261715
Jan 2012541313
Feb 2012521017
Mar 2012352127
Apr 2012211712
May 2012512726
Jun 201215715
Jul 2012272022
Aug 2012311217
Sep 2012362123
Oct 2012321624
Nov 2012441327
Dec 2012241224
Jan 20134030128
Feb 2013201070
Mar 2013191318
Apr 201322714
May 2013251625
Jun 2013171212
Jul 2013231013
Aug 2013583
Sep 201326138
Oct 2013211717
Nov 201314413
Dec 20139812
Jan 201424713
Feb 2014171411
Mar 20141196
Apr 201426815
May 2014131513
Jun 201413715
Jul 2014141311
Aug 20141558
Sep 201414148
Oct 2014211820
Nov 2014411410
Dec 201431129
Jan 20151767
Feb 2015151017
Mar 201523168
Apr 201519138
May 2015251818
Jun 2015242712
Jul 2015332533
Aug 2015221213
Sep 2015211210
Oct 2015171916
Nov 2015131715
Dec 201510163
Jan 2016302324
Feb 2016133326
Mar 201618924
Apr 2016281828
May 20169146
Jun 2016121420
Jul 2016212125
Aug 2016192325
Sep 201651810
Oct 201633214
Nov 2016123418
Dec 20163267
Jan 20170235
Feb 20171198
Mar 20174214
Apr 201702312
May 20172125
Jun 20172148
Jul 20170215
Aug 20173162
Sep 20172244
Oct 201712215
Nov 201712520
Dec 201722012
Jan 201833112
Feb 201802216
Mar 201803010
Apr 201805316
May 20180387
Jun 20180342
Jul 20180467
Aug 201824714
Sep 20180378
Oct 201803028
Nov 20182294
Dec 201833105
Jan 20192834
Feb 20193352
Mar 20191465
Apr 20191645
May 20192424
Jun 20192137
Jul 20193365
Aug 201959210
Sep 20192744
Oct 20193015
Nov 20194533
Dec 20192812
Jan 20203646
Feb 20203527
Mar 20203038
Apr 20203012
May 20201411
Jun 20201413
Jul 20202502
Aug 20201025
Sep 20201120
Oct 20202144
Nov 2020812
Dec 20202910
Jan 202128126
Feb 202122154
Mar 20215998
Apr 20216529
May 20219155
Jun 20211952
Jul 20212974
Aug 20211553
Sep 2021795
Oct 20212663
Nov 20213524
Dec 20212013
Jan 20222929
Feb 20221512
Mar 20221321
Apr 20221922
May 20221424
Jun 20222112
Jul 20221325
Aug 20221712

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 79 (3)
Molecular Pharmacology
Vol. 79, Issue 3
1 Mar 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor

Nuska Tschammer, Stefan Bollinger, Terry Kenakin and Peter Gmeiner
Molecular Pharmacology March 1, 2011, 79 (3) 575-585; DOI: https://doi.org/10.1124/mol.110.068106

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor

Nuska Tschammer, Stefan Bollinger, Terry Kenakin and Peter Gmeiner
Molecular Pharmacology March 1, 2011, 79 (3) 575-585; DOI: https://doi.org/10.1124/mol.110.068106
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Upacicalcet binds to the amino acid binding site of CaSR
  • Characterization of GRD and LCCH3 from Human Louse
  • Resveratrol Acts as an NR4A1 Antagonist in Lung Cancer
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics